Hepatitis E Virus: A Review Paper

Namrata Arya; Dr.  Arminder Kaur

doi:10.55524/ijirem.2022.9.1.78

Abstract

In tropical and subtropical areas, the hepatitis E virus is significant source of outbursts and occasional instances of virus hepatitis, although it is uncommon in industrialized nations. The virus is spread via the facesoral path, with dirty consumption of water serving as the most common carrier. In most individuals, hepatitis caused by HEV infection causes moderately severe jaundice that goes away on its own. Infection mostly affects young people between the ages of 15 and 30, with a mortality incidence of 0.5 to 3.0%. The mortality rate during pregnancy, on the other hand, is about 15 to 25%. Abortion, premature births, or the mortality of a live-born baby within hours of birth are all possible outcomes of hepatitis E infections throughout childbirth. HEV is a zoometric virus since it may be found in both wild and domestic animals. Human HEV identified in those regions is closely linked to viruses discovered from pigs in the United States and Taiwan. Because the swine and human viruses have a strong genetic connection, pigs may be a HEV reservoir. Pigs dung may be a cause of HEV contamination of irrigation water or coastal waters in regions where swine are farmed, with concurrent contamination of crops or shellfish. Industrialized nations' growing globalization of nutrition marketplaces has the power to spread HEV to other parts of the globe. The goal of this study is to address many elements of hepatitis E, such as the causative agent, illness, HEV-targeted populations, epidemiology, viral transmission, viral detection, diagnostics, and the part of creatures as possible virus vectors.

Keywords

Hepatitis, Disease, Food Borne, Virus, Zoo.

References

[1] G. Bricks et al., “Seroprevalence of hepatitis E virus in chronic hepatitis C in Brazil,” Brazilian J. Infect. Dis., 2018.

[2] R. Ledesma, I. Nimgaonkar, and A. Ploss, “Hepatitis e virus replication,” Viruses. 2019.

[3] P. P. Primadharsini, S. Nagashima, and H. Okamoto, “Genetic variability and evolution of hepatitis e virus,” Viruses. 2019.

[4] D. Lapa, M. R. Capobianchi, and A. R. Garbuglia, “Epidemiology of hepatitis E virus in European countries,” International Journal of Molecular Sciences. 2015.

[5] A. T. Aslan and H. Y. Balaban, “Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment,” World Journal of Gastroenterology. 2020.

[6] M. L. Garrido, M. L. R. Toso, S. Raffa, and V. I. Descalzi, “Acute hepatitis ‘E’ virus with features of autoimmunity. A case report,” Acta Gastroenterol. Latinoam., 2021.

[7] S. Sahra, A. Jahangir, Q. Z. Iqbal, N. Mobarakai, A. Glaser, and A. Jahangir, “Co-infection of hepatitis E virus and Plasmodium falciparum malaria: A genuine risk in sub-Saharan Africa,” Parasites and Vectors, 2021.

[8] D. Thiry et al., “Hepatitis E Virus and Related Viruses in Animals,” Transboundary and Emerging Diseases. 2017.

[9] D. B. Smith et al., “Update: Proposed reference sequences for subtypes of hepatitis E virus (species Orthohepevirus A),” J. Gen. Virol., 2020.

[10] X. Ju and Q. Ding, “Hepatitis e virus assembly and release,” Viruses. 2019.

[11] S. Lhomme, O. Marion, F. Abravanel, J. Izopet, and N. Kamar, “Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections,” Journal of Clinical Medicine. 2020.

[12] B. Wang, D. Harms, X. Lou Yang, and C. T. Bock, “Orthohepevirus C: An expanding species of emerging hepatitis e virus variants,” Pathogens. 2020.

[13] R. Veronesi, M. Morach, E. Hübschke, C. Bachofen, R. Stephan, and M. Nüesch-Inderbinen, “Seroprevalence of hepatitis E virus in dogs in Switzerland,” Zoonoses Public Health, 2021.

[14] P. Li et al., “The global epidemiology of hepatitis E virus infection: A systematic review and meta-analysis,” Liver Int., 2020.

[15] M. B. Pisano et al., “Hepatitis E virus in South America: The current scenario,” Liver International. 2018.

[16] H. Leblebicioglu and R. Ozaras, “Hepatitis E virus infection in Turkey: A systematic review,” Annals of Clinical Microbiology and Antimicrobials. 2018.

[17] R. M. Fu, C. C. Decker, and V. L. Dao Thi, “Cell culture models for hepatitis E virus,” Viruses. 2019.

[18] M. Mazalovska and J. C. Kouokam, “Progress in the production of virus-like particles for vaccination against hepatitis E virus,” Viruses. 2020.

[19] Y. E. Raji, O. P. Toung, N. Mohd Taib, and Z. Bin Sekawi, “A systematic review of the epidemiology of Hepatitis E virus infection in South–Eastern Asia,” Virulence. 2021.

[20] G. Bricks et al., “Previous hepatitis E virus infection, cirrhosis and insulin resistance in patients with chronic hepatitis C,” Brazilian J. Infect. Dis., 2019.

[21] B. Wilhelm, L. Waddell, J. Greig, and I. Young, “A systematic review and meta-analysis of predictors of human hepatitis E virus exposure in non-endemic countries,” Zoonoses Public Health, 2020.

[22] C. Adlhoch et al., “Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15,” J. Clin. Virol., 2016.

[23] H. Barragué et al., “Chronic hepatitis e virus infection in a cirrhotic patient,” Med. (United States), 2017.

[24] M. C. López O., A. Duque Jaramillo, and M. C. Navas N., “Clinical and epidemiology of hepatitis E virus infection,” Revista Colombiana de Gastroenterologia. 2018.

[25] T. L. Meister, J. Bruening, D. Todt, and E. Steinmann, “Cell culture systems for the study of hepatitis E virus,” Antiviral Research. 2019.

Cites this article as

N. Arya, D. . A. Kaur, "Hepatitis E Virus: A Review Paper", International Journal of Innovative Research in Engineering and Management (IJIREM), Vol-9, Issue-1, Page No-376-379, 2022. Available from: https://doi.org/10.55524/ijirem.2022.9.1.78